Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,152 public trials 2,021 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Active, Not Recruiting

A Study Assessing Adverse Events and Disease Activity of Intravenously (IV) Infused Telisotuzumab Adizutecan in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer

NCT06614192

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • City of Hope National Medical Center /ID# 267875 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 270655 Irvine, California, United States
  • USC Norris Comprehensive Cancer Center /ID# 268131 Los Angeles, California, United States
  • Lutheran Medical Center- Cancer Centers of Colorado /ID# 268175 Golden, Colorado, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

NCT06131398

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +29 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Alliance for Multispecialty Research - Kansas City Merriam, Kansas, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View all 25 locations
View Trial Details
Active, Not Recruiting

A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

NCT05094336

Conditions
Advanced MTAP-null Solid Tumors, Biliary Tract Diseases, Biliary Tract Neoplasms, +29 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • California Research Institute Glendale, California, United States
  • Fomat Medical Research Oxnard, California, United States
  • University of California at SF San Francisco, California, United States
View all 75 locations
View Trial Details
Active, Not Recruiting

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

NCT02568267

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +91 more
Locations
  • Dignity Health St Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope Duarte - Comprehensive Cancer Center, Investigational Drug Services Duarte, California, United States
View all 130 locations
View Trial Details
Active, Not Recruiting

Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

NCT04704934

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
Locations
  • Instituto Medico Especializado Alexander Fleming Colegiales, Buenos Aires F.D., Argentina
  • IONC Instituto Oncologico de Cordoba - Fundacion Richardet Longo Nueva Cordoba, Córdoba Province, Argentina
  • Exelsus San Miguel de Tucumán, Tucumán Province, Argentina
  • Fundacion Cenit Buenos Aires, Argentina
View all 156 locations
View Trial Details
Active, Not Recruiting

A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer

NCT05723562

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Albuquerque, New Mexico, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Pittsburgh, Pennsylvania, United States
View all 42 locations
View Trial Details

Related conditions